Furthermore a functional link between KRASG12D mutation and NLRP3 activation by the KRAS/RAC1/ROS/NLRP3 axis has been demonstrated both in KRAS mutant murine bone marrow (BM) and in leukemia human cells [70]. This evidence concerns the gene KRAS and leukemia.